Seeking Alpha
 

Nektar Therapeutics (NKTR)

- NASDAQ
  • LaboMedic | Send Message 26 Jan

    $NKTR Roth Capital Pounds The Table On Nektar Therapeutics http://bit.ly/1Bs36Pg
    Reply
      • LaboMedic | Send Message 21 Dec 2014

        Analyst Highlights - Week 51 - Healthcare (Part IV) http://goo.gl/Ks9kc9 $AVNR $NEO $SNSS $NKTR $ALNY $ARRY
        Reply
          • LaboMedic | Send Message 2 Dec 2014

            $NKTR Roth Capital Reiterates Buy On Nektar Therapeutics Following BAX-855 BLA Submission http://bit.ly/12mHMP7
            Reply
              • LaboMedic | Send Message 30 Nov 2014

                Analyst Highlights - Week 48 - Healthcare (Part III) http://goo.gl/ZJhaqq $ILMN $NKTR $RGLS $BDSI $RNA
                Reply
                  • LaboMedic | Send Message 28 Nov 2014

                    $NKTR Nektar Therapeutics: Roth Capital Sees 40% Probability Of Success In NKTR-102 Phase 3 Trial http://bit.ly/1FBCpaJ
                    Reply
                      • BiotechX | Send Message 25 Nov 2014

                        $NKTR - Finally investors start to recognize the potential here...2015 will be great for NKTR!!
                        Reply
                          • Looking For Diogenes | Send Message 11 Nov 2014

                            Nektar Therapeutics: 2015 - The Year Of Great Things? $NKTR http://seekingalpha.com/a/1l7wt
                            Reply
                              • LaboMedic | Send Message 10 Nov 2014

                                $NKTR Transformational Quarter Sets Nektar Up for Multiple Commercial Launches, Says Roth Capital http://bit.ly/1u2x9LA
                                Reply
                                  • LaboMedic | Send Message 7 Nov 2014

                                    $NKTR Brean Capital Maintains Buy On Nektar Therapeutics Following 3Q14 Results http://bit.ly/1Ebhb2I
                                    Reply
                                      • LaboMedic | Send Message 15 Oct 2014

                                        $NKTR Nektar Therapeutics: BAX-855 And Movantik Wins Not Being Reflected In The Stock, Says Roth Capital http://bit.ly/ZDUeba
                                        Reply
                                          NKTR vs. ETF Alternatives
                                          Company Description
                                          Nektar Therapeutics, Inc., is a clinical-stage biopharmaceutical company developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms, which are designed to improve the benefits of drugs for patients.
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States